PHOENIX-OITB Service Portfolio out now!
PHOENIX consortium is composed of experienced and well-established beneficiaries in their respective fields, which provide PHOENIX-OITB all necessary infrastructures to cover all the aspects of GMP manufacturing of nano-pharmaceuticals from development and technology transfer through scale up to regulatory guidance. PHOENIX-OITB is established as a unified body and operational structure to sustainably coordinate the value chain that will merge all services necessary to develop solutions for end-users. The core PHOENIX-OITB services are designed to meet the expectations of the whole path from initial idea to the market. PHOENIX-OITB makes best use of existing data and expertise by compiling the existing know-how, expertise and technologies within the consortium in “one pot” to be served to the end-users of PHOENIX-OITB.
The PHOENIX-OITB service portfolio compiles a list of the services provided by the PHOENIX-OITB. The services range from non-GMP (i.e. R&D and scale-up phase) to GMP (i.e. production phase) environment.
It is divided into 5 different categories. Each category includes a list of services, all of which together cover the different topics needed for the development of nano-pharmaceuticals from early stage to entry into clinical trials.